Giant cell arteritis
Related Experiment Video
Updated: Jul 8, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Helen V Danesh-Meyer1, Peter J Savino
1Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
Purpose Of Review:
Giant cell arteritis is an important cause of blindness in patients over 60 years of age. We attempt to identify the important clinical aspects in the diagnosis and management of this disorder, so that treatment may be instituted expeditiously to limit visual loss.
Recent Findings:
In addition, we identify current areas of standards in the investigation and treatment of patients with suspected giant cell arteritis.
Summary:
We review some newer treatment possibilities, based on recently proposed immunologic models of giant cell arteritis, that may lead to newer treatment modalities.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
